Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
September 28, 2018
Oslo Cancer Cluster

Autumn is an eventful time

September is the first month of autumn here in Norway and at Oslo Cancer Cluster we get busier with each falling leaf.

Autumn is an eventful time

September is the first month of autumn here in Norway and at Oslo Cancer Cluster we get busier with each falling leaf.

September is the first month of autumn here in Norway and at Oslo Cancer Cluster we get busier with each falling leaf. We have been to Stockholm to participate in the Nordic Life Science Days and we have had prominent visitors from the USA here in the Innovation Park to enlighten us about a pioneer project run by Cancer Registry of Norway and Lawrence Livermore National Laboratory. A new and promising collaboration is also initiated between Oslo Cancer Cluster member Vaccibody and American Nektar Therapeutics.

We wish you a cosy indoor read,
The Oslo Cancer Cluster Team

What is driving the next wave of innovation in cancer immunotherapy?

Get some answers from the expert panel in this easy to read report with highlights from the oncology session that took place at the conference Nordic Life Science Days in Stockholm earlier this month.

Get some answers

A new combination

Norwegian personalized cancer vaccine meets American immuno-therapy drug in this collaboration between Vaccibody and American biopharmaceutical company Nektar Therapeutics.

The vaccine-drug combination

Why did the U.S. Ambassador visit us?

This is a story about the unique American-Norwegian collaboration that combines the best health data with the most powerful computers in a pioneer project.

Keep reading

Live Podcast TODAY

Today, our General Manager Ketil Widerberg is a guest in a special Radium podcast about trends in health innovation. The live podcast is part of Oslo Innovation Week.

Listen to the podcast

Last updated:
September 28, 2018

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail

September is the first month of autumn here in Norway and at Oslo Cancer Cluster we get busier with each falling leaf. We have been to Stockholm to participate in the Nordic Life Science Days and we have had prominent visitors from the USA here in the Innovation Park to enlighten us about a pioneer project run by Cancer Registry of Norway and Lawrence Livermore National Laboratory. A new and promising collaboration is also initiated between Oslo Cancer Cluster member Vaccibody and American Nektar Therapeutics.

We wish you a cosy indoor read,
The Oslo Cancer Cluster Team

What is driving the next wave of innovation in cancer immunotherapy?

Get some answers from the expert panel in this easy to read report with highlights from the oncology session that took place at the conference Nordic Life Science Days in Stockholm earlier this month.

Get some answers

A new combination

Norwegian personalized cancer vaccine meets American immuno-therapy drug in this collaboration between Vaccibody and American biopharmaceutical company Nektar Therapeutics.

The vaccine-drug combination

Why did the U.S. Ambassador visit us?

This is a story about the unique American-Norwegian collaboration that combines the best health data with the most powerful computers in a pioneer project.

Keep reading

Live Podcast TODAY

Today, our General Manager Ketil Widerberg is a guest in a special Radium podcast about trends in health innovation. The live podcast is part of Oslo Innovation Week.

Listen to the podcast

Last updated:
September 28, 2018

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail